Microalbuminuria: Clinical Trials

11 trials for Microalbuminuria, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 completed, 3 unknown, 2 terminated, 1 recruiting. 11 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 411Completed 5, Unknown 3, Terminated 2, Recruiting 1

Follow Microalbuminuria: new trials by email Literature Review of Microalbuminuria trials Research Report on Microalbuminuria

Trials (filtered) newest first · largest first

All 11 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
ACE Reno, Pico Cell Matrix and Its Effect on eGFR in Chronic Kidney Diseases
ACE Reno - Hypertensive Nephropathy, Auto Immune Disorders
Phase 4RecruitingAce Cells Lab Limited3002025-09-202025-09-23
Effects of SGLT2 Inhibitor on Hemodynamic Parameters in Resistant Hypertensive Subjects
Dapagliflozin 10mg, Glibenclamide 5Mg Tablet - Hypertension, Diabetes Mellitus, Type 2
Phase 4CompletedUniversity of Campinas, Brazil162016-07-012018-05-08
Saxagliptin's Effects on Microalbuminuria Improvement in Type 2 Diabetic Patients
Saxagliptin, glimepiride - Microalbuminuria, Microalbuminuria /Creatinine Ratios ACR
Phase 4UnknownThe Second Hospital of Nanjing Medical University882015-06-012015-07-28
Evaluate the Efficacy of Fenofibrate on Microalbuminuria
fenofibrate - Microalbuminuria
Phase 4UnknownBeijing Chao Yang Hospital2002014-12-012014-12-11
Use of Sitagliptin to Decrease Microalbuminuria
Sitagliptin, Placebo - Type 2 Diabetes, Microalbuminuria
Phase 4TerminatedUniversity of Missouri-Columbia1422014-01-012017-08-10
Effects of Low Sodium Intake on the Anti-proteinuric Efficacy in Hypertensive Patient With Olmesartan
Intensive education of low salt diet - Hypertension, Chronic Kidney Disease
Phase 4CompletedSeoul National University Bundang Hospital2692012-02-012014-12-18
Amiloride for Resistant Hypertension
Amiloride - Hypertension, Type 2 Diabetes Mellitus
Phase 4CompletedIb Abildgaard Jacobsen802010-11-012014-04-24
Triple Blockade of the Renin Angiotensin Aldosterone System in Diabetic (Type 1&2) Proteinuric Patients
Aliskiren - Microalbuminuria, Macroalbuminuric Diabetic Nephropathy
Phase 4TerminatedCook County Health22009-08-012013-10-28
To Assess the Effects of Valsartan on Albuminuria/Proteinuria in Hypertensive Patients With Type 2 Diabetes Mellitus
valsartan - Microalbuminuria, Proteinuria
Phase 4CompletedNovartis5092007-06-012017-02-23
Optimal Dose of Irbesartan for Renoprotection in Type 2 Diabetic Patients With Persistent Microalbuminuria
irbesartan - Type 2 Diabetes, Microalbuminuria
Phase 4CompletedSteno Diabetes Center Copenhagen522003-09-012006-05-18
Aspirin and Enalapril in Microalbuminuric Type 2 Diabetes Mellitus Patients
aspirin - Diabetes Mellitus, Microalbuminuria
Phase 4UnknownHospital de Clinicas de Porto Alegre202003-03-012007-01-29

Narrower conditions

Diabetes Mellitus, Type 2 (4)  ·  Hypertension (4)  ·  Diabetes Mellitus (3)  ·  Albuminuria (2)  ·  Proteinuria (2)  ·  Renal Insufficiency, Chronic (2)  ·  Cardiomegaly (1)  ·  Diabetic Nephropathies (1)  ·  Hypertensive Nephropathy (1)  ·  Kidney Diseases (1)  ·  Obesity (1)

Broader conditions

Endocrine System Diseases (7)  ·  Glucose Metabolism Disorders (6)  ·  Metabolic Diseases (6)  ·  Nutritional and Metabolic Diseases (6)  ·  Pathological Conditions, Signs and Symptoms (5)  ·  Cardiovascular Diseases (4)  ·  Diabetes Mellitus (4)  ·  Female Urogenital Diseases (4)  ·  Female Urogenital Diseases and Pregnancy Complications (4)  ·  Male Urogenital Diseases (4)  ·  Signs and Symptoms (4)  ·  Urogenital Diseases (4)  ·  Urologic Diseases (4)  ·  Vascular Diseases (4)  ·  Urination Disorders (3)

Interventions

Amiloride (1)  ·  Angiotensin-Converting Enzyme Inhibitors (1)  ·  Aspirin (1)  ·  Diet, Sodium-Restricted (1)  ·  Fenofibrate (1)  ·  Glyburide (1)  ·  Irbesartan (1)  ·  Sitagliptin Phosphate (1)  ·  Tablets (1)  ·  Valsartan (1)  ·  aliskiren (1)  ·  dapagliflozin (1)  ·  glimepiride (1)  ·  saxagliptin (1)

Sponsors

Ace Cells Lab Limited (1)  ·  Beijing Chao Yang Hospital (1)  ·  Cook County Health (1)  ·  Hospital de Clinicas de Porto Alegre (1)  ·  Ib Abildgaard Jacobsen (1)  ·  Novartis (1)  ·  Seoul National University Bundang Hospital (1)  ·  Steno Diabetes Center Copenhagen (1)  ·  The Second Hospital of Nanjing Medical University (1)  ·  University of Campinas, Brazil (1)  ·  University of Missouri-Columbia (1)

Countries

Brazil (2)  ·  Denmark (2)  ·  Egypt (2)  ·  United States (2)  ·  South Korea (1)

Top investigators

Bum Soon Choi, PhD (1)  ·  Chun-Soo Lim, PhD (1)  ·  Dong Ki Kim, PhD (1)  ·  Dr. Alaa Abdelkarim M Fouad, MRCPUK SEC (1)  ·  Eduardo G Camargo (1)  ·  Guido Lastra Gonzalez, MD (1)  ·  Hans-Henrik Parving (1)  ·  Ho Jun Chin, PhD (1)  ·  Ib A Jacobsen, DMSc (1)  ·  Jung-Hwan Park, PhD (1)  ·  Kasper Rossing (1)  ·  Pete Antonopoulos, PharmD (1)  ·  Rodrigo Modolo, MD, PhD (1)

Results publications

PMID 16105050, PMID 16612330, PMID 20388897, PMID 21206136, PMID 22025647, PMID 24026560, PMID 25531146, PMID 26098847, PMID 32446306, PMID 33782940, PMID 34164803, PMID 37612109